Taohong siwu decoction attenuates AIM2 and NLRC4 inflammasomes by ameliorates deoxyribonucleic acid damage after ischemic stroke.

导出 LinkOut

翻译打印收藏纠错

作者： Ni,Wang ^[1] ; Furui,Chu ^[2] ; Lijuan,Zhang ^[3] ; Changyi,Fei ^[4] ; Chao,Yu ^[5] ; Sujun,Xue ^[1] ; Yongzhong,Wang ^[2] ; Ling,Fang ^[3] ; Daiyin,Peng ^[4] ; Xianchun,Duan ^[5] ; Weidong,Chen ^[1]

作者单位： Department of Pharmacy, The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei, China. ^[1] School of Pharmacy, Anhui University of Chinese Medicine, Hefei, China. ^[2] MOE-Anhui Joint Collaborative Innovation Center for Quality Improvement of Anhui Genuine Chinese Medicinal Materials, Hefei, China. ^[3] Anhui Province Key Laboratory of Chinese Medicinal Formula, Hefei, China. ^[4] Key Laboratory of Xin'an Medicine (Anhui University of Chinese Medicine), Ministry of Education, Hefei, China. ^[5] Department of Pharmacy, The First Affiliated Hospital of Anhui Medical University, Hefei, China. ^[6]

关键词 AIM2 NLRC4 Taohong Siwu Decoction inflammasomes ischemic stroke

DOI 10.3389/fphar.2022.954867

PMID 36034843

发布时间 2022-08-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in pharmacology

2022年13卷

954867页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Taohong siwu decoction attenuates AIM2 and NLRC4 inflammasomes by ameliorates deoxyribonucleic acid damage after ischemic stroke.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Taohong siwu decoction attenuates AIM2 and NLRC4 inflammasomes by ameliorates deoxyribonucleic acid damage after ischemic stroke.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

检索历史清除